The Europe Laparoscopic Power Morcellators Market would witness market growth of 7.9% CAGR during the forecast period (2021-2027).
Laparoscopic surgeries are considered as minor surgeries. They are accompanied by a shorter post-operative recovery time. The surgeries are performed with the help of laparoscopic power morcellators which reduces the risk of infection as compared to those that involve abdominal incisions such as hysterectomy or myomectomy.
Uterine sarcoma is a type of cancer. It is common in women who undergo surgery for uterine fibroids which are noncancerous growths in a woman's uterus. Prior to surgery, it was difficult to distinguish between a uterine sarcoma and a uterine fibroid with available tests. Women having uterine sarcomas that are presumed as uterine fibroids when undergoing laparoscopic power morcellators myomectomy or hysterectomy, there is a risk of spreading cancerous tissue away from the uterus. Therefore, this condition worsens the possibility of long-term survival in women.
The demand for laparoscopic power morcellators is high in the European counties. It is due to the increasing adoption of technologically advanced products in the healthcare sector in this region. The increasing number of women who are suffering from uterine fibroids is very high among the population. This will spur opportunities in the laparoscopic power morcellators market in this region. The medical infrastructure is very advanced in the UK.
Uterine fibroids are common benign tumors in women. They need to have a hysterectomy or uterus-preserving procedures which are surgical procedure that helps in managing their symptoms. Myomectomy is a surgical procedure that involves the removal of fibroids from the uterus. Many advanced devices are available including laparoscopic power morcellators that are used in these surgeries. The morcellation is used in laparoscopic total hysterectomy to remove the uterus. In recent years, non-invasive and minimally invasive surgeries have gained high popularity. It is due to the lesser risk associated with these procedures. As there is a smaller cut in non-invasive surgeries and thus, there is minimum postoperative pain and ensure a speedy recovery. Therefore, the demand for including laparoscopic power morcellators is increasing in Europe.
The Germany market dominated the Europe Hysterectomy Market by Country in 2020, thereby, achieving a market value of $5,531.4 Thousands by 2027. The UK market is exhibiting a CAGR of 6.2% during (2021 - 2027). Additionally, The France market is poised to witness a CAGR of 8.6% during (2021 - 2027).
Based on Application, the market is segmented into Hysterectomy, Myomectomy and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Laparoscopic Power Morcellators Market Size will Hit $176.2 Million by 2027, at a CAGR of 8.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Karl Storz SE & Co. KG, Cook Medical, Inc. (Cook Group), Olympus Corporation, Johnson and Johnson, Lina Medical, Nouvag AG, Rudolf Medical GmbH, OWA- Electronic GmbH & Co. KG, and Richard Wolf GmbH.
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
